Aptose Biosciences Inc (NAS:APTO)
$ 0.3737 0.0123 (3.4%) Market Cap: 6.62 Mil Enterprise Value: -1.11 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Aptose Biosciences Inc Annual Shareholders Meeting Transcript

Jun 02, 2020 / 05:00PM GMT
Release Date Price: $111.15 (-2.76%)
William G. Rice
Aptose Biosciences Inc. - Chairman, President & CEO

Good morning, all. I would like to call to order this Annual Meeting of Shareholders of Aptose Biosciences Inc. I'm Dr. William Rice, Chairman of the Board of Directors, President and Chief Executive Officer of Aptose. I'll be serving as the Chair for today's meeting.

Joining me today are other directors, including Dr. Denis Burger, our Lead Independent Director; Dr. Erich Platzer; Mr. Warren Whitehead; Ms. Carol Ashe; Ms. Caroline Loewy; and Dr. Mark Vincent, who have joined us on the line. Other members of management also joining us today are Mr. Greg Chow, Executive Vice President and Chief Financial Officer; Dr. Joti Marango, Senior Vice President and Chief Business Officer; Dr. Rafael Bejar, Senior Vice President and Chief Medical Officer; and Mr. Victor Montalvo-Lugo, Vice President of Clinical Operations.

It's my pleasure to welcome the shareholders and employees of Aptose, members of the news media and other invited guests to our first shareholders' meeting to be held exclusively online. This year,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot